Remove Healthcare Professional Remove Hospital Remove Information Remove Manufacturing
article thumbnail

Hearing Loss in Geriatrics and Palliative Care: A Podcast with Nick Reed and Meg Wallhagen

GeriPal

And when you think about that, they’re hearing pieces of the information and their brain is trying to make sense of it. Including more hospital utilization or healthcare utilization, maybe cognitive impairment issues. My own work focuses on hospitalization and health utilization over time. Is that right?

IT 102
article thumbnail

Advance Care Planning Discussion: Susan Hickman, Sean Morrison, Rebecca Sudore, and Bob Arnold

GeriPal

So it’s an example of something that can start outside of the healthcare system and move its way in. Ideally, there’ll be a place in the chart that actually captures the name of that person and their contact information. So every transition into the hospital, every transition out of the hospital.

Illness 72
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psilocybin in Serious Illness: James Downar, Ali John Zarrabi and Margaret Ross

GeriPal

Vincent’s Hospital in Melbourne, Australia. Alex 06:03 Is psilocybin that’s used for medicinal purposes in your studies, for example, is that manufactured or is it derived directly from mushrooms? We dedicated team working with cancer and palliative medicine in our hospital. James, welcome to the GeriPal Podcast.

Illness 107
article thumbnail

Aging and Climate Change: Karl Pillemer, Leslie Wharton, & Ruth McDermott-Levy

GeriPal

And so we do see hospital admissions for heat exposure and certainly cardiovascular and respiratory problems related to air pollution with climate change and also cognitive problems. What’s our role in changing the healthcare system, in our own healthcare system. What does that actually look like? We really do not.

article thumbnail

Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana

FDA Law

For each factor, the NPRM noted that DEA’s position is that additional information during the rulemaking will further inform about the appropriate schedule for marijuana. The NPRM noted that DEA “has not yet made a determination as to its views of the appropriate schedule for marijuana.” Basis at 7-8; NPRM at 44,614.

article thumbnail

COVID Updates: A Podcast with Peter Chin-Hong and Lona Mody

GeriPal

But it feels the same in that I was on call a lot over the summer, and I took care of a lot of people behind those hospital walls. And we don’t see hospitals being strained as much anymore. You know, of course, serious disease, hospitalization and death. And, you know, some people are still getting very sick.